Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
As of close of business last night, Oncology Institute Inc’s stock clocked out at $0.31, up 3.31% from its previous closing price of $0.30. In other words, the price has increased by $3.31 from its previous closing price. On the day, 0.52 million shares were traded. TOI stock price reached its highest trading level at $0.3189 during the session, while it also had its lowest trading level at $0.2723.
Ratios:
To gain a deeper understanding of TOI’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.27 and its Current Ratio is at 2.49. In the meantime, Its Debt-to-Equity ratio is 7.94 whereas as Long-Term Debt/Eq ratio is at 7.51.
On September 14, 2022, Guggenheim started tracking the stock assigning a Buy rating and target price of $7.
On August 15, 2022, Jefferies started tracking the stock assigning a Buy rating and target price of $10.Jefferies initiated its Buy rating on August 15, 2022, with a $10 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 26 ’24 when Hively Brad bought 250,000 shares for $0.17 per share. The transaction valued at 42,500 led to the insider holds 616,753 shares of the business.
Hively Brad bought 50,000 shares of TOI for $7,500 on Dec 02 ’24. The Director now owns 666,753 shares after completing the transaction at $0.15 per share. On Jan 29 ’24, another insider, Havencrest Healthcare Partners, who serves as the 10% Owner of the company, sold 8,637 shares for $2.12 each. As a result, the insider received 18,310 and left with 0 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TOI now has a Market Capitalization of 23551772 and an Enterprise Value of 92398360. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.06 while its Price-to-Book (P/B) ratio in mrq is 1.52. Its current Enterprise Value per Revenue stands at 0.256 whereas that against EBITDA is -1.611.
Stock Price History:
The Beta on a monthly basis for TOI is 0.14, which has changed by -0.8519608 over the last 52 weeks, in comparison to a change of 0.22263205 over the same period for the S&P500. Over the past 52 weeks, TOI has reached a high of $2.45, while it has fallen to a 52-week low of $0.13. The 50-Day Moving Average of the stock is 31.46%, while the 200-Day Moving Average is calculated to be -39.15%.
Shares Statistics:
It appears that TOI traded 1.83M shares on average per day over the past three months and 767860 shares per day over the past ten days. A total of 75.56M shares are outstanding, with a floating share count of 36.80M. Insiders hold about 51.29% of the company’s shares, while institutions hold 16.30% stake in the company. Shares short for TOI as of 1730332800 were 247975 with a Short Ratio of 0.18, compared to 1727654400 on 252527. Therefore, it implies a Short% of Shares Outstanding of 247975 and a Short% of Float of 0.5.
